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OBJECTIVES: To develop a scoring system model that pre-
dicts mortality within 30 days of admission of patients older
than 80 years admitted to intensive care units (ICUs).
DESIGN: Prospective cohort study.
SETTING: A total of 306 ICUs from 24 European countries.
PARTICIPANTS: Older adults admitted to European ICUs
(N = 3730; median age = 84 years [interquartile range = 81-87
y]; 51.8%male).
MEASUREMENTS: Overall, 24 variables available during
ICU admission were included as potential predictive variables.
Multivariable logistic regressionwas used to identify independent
predictors of 30-day mortality. Model sensitivity, speciﬁcity, and
accuracy were evaluated with receiver operating characteristic
curves.
RESULTS: The 30-day-mortalitywas 1562 (41.9%). Inmulti-
variable analysis, these variables were selected as independent
predictors of mortality: age, sex, ICU admission diagnosis,
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Clinical Frailty Scale, Sequential Organ Failure Score, invasive
mechanical ventilation, and renal replacement therapy. The
discrimination, accuracy, and calibration of the model were
good: the area under the curve for a score of 10 or higher was
.80, and the Brier score was .18. At a cut point of 10 or higher
(75% of all patients), the model predicts 30-day mortality in
91.1% of all patients who die.
CONCLUSION: A predictive model of cumulative events
predicts 30-day mortality in patients older than 80 years
admitted to ICUs. Future studies should include other poten-
tial predictor variables including functional status, presence
of advance care plans, and assessment of each patient’s
decision-making capacity. J Am Geriatr Soc 00:1–5, 2019.
Key words: critical care; prognosis; older adults; predict;
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More than 10% of the patients admitted to the intensivecare unit (ICU) are 80 years and older.1 This propor-
tion of “very old intensive care patients” (VIPs) is estimated to
increase up to 36% in 2025.2,3 However, once VIPs have been
admitted to the ICU for an acute medical reason, their overall
30-day mortality is high. The frailer patients in particular have
a high mortality.4 Despite careful patient selection before ICU
admission, more than half of these VIPs will die or will experi-
ence major functional deterioration in the 6 months following
their admission.5,6
As a result of our current uncertainty in predicting which
VIPs could potentially beneﬁt from ICU treatment, we often
offer them an “ICU trial.” This means admitting VIPs to an
ICU, offering them life-sustaining treatment for a period of
2 to 3 days, and then reevaluating if they show any improve-
ment. If patients deteriorate, limitations in life-sustaining ther-
apies would be required.7 For ICU physicians, this ICU trial
postpones the difﬁcult ICU admission triage decision by a few
days, and by then, some patients have improved. However,
some will still receive life-sustaining therapy, and a decision to
continue treatment should be discussed with the patient or his
or her legal representatives.8 Inevitably, during such shared
decision-making processes, the question of chances of survival
emerges. Most intensivists estimate a patient’s chances of out-
come on experience and on preferences. Current severity scor-
ing systems are not tailored for VIPs,1 and proposed models
for VIP are not precise enough.9,10
We hypothesize that a cumulative prognostic score can pre-
dict 30-day mortality and thus support physicians and relatives
with the decision to continue care or start a new treatment.
METHODS
We present only a very brief discussion of methods here. A
more elaborate description of our methods, adhering to all
Transparent Reporting of a Multivariable Prediction Model
for Individual Prognosis or Diagnosis (TRIPOD) statements,11
is provided in SupplementaryMaterials S1.
In short, all patients older than 80 years who were acutely
admitted to participating ICUs in 24 European countries were
included in this study.4,7 The mortality 30 days after ICU
admissionwas the primary outcome.
Based on variables present at admission (eg, age, sex, rea-
son for ICU admission, the abbreviatedClinical Frailty Scale)12
or treatments provided during ICU stay (eg, worst Sequential
Organ Failure Assessment [SOFA], (non-)invasive mechanical
ventilation, use of vasoactive drugs, renal replacement therapy
[RRT]), a multivariable logistic regression model was con-
structed. The discrimination, accuracy, and calibration of the
model were assessed13,14 before a simple bedside model was
constructed. This simple bedside model was based on the beta
of each predictor in themodel as described previously.15
The total number of points assigned to each patient is
called the cumulative prognostic score (CPS) and correlates
with 30-day mortality. The performance of the bedside
model (the sensitivity and speciﬁcity at several cutoff points
of the CPS) is assessed.
RESULTS
Participants
In total, 306 ICUs from 24 countries participated and included
5187 VIPs. Of these patients, 4252 were acutely admitted.
Follow-up at 30 days with complete data on all variables was
obtained in 88% (3730/4252). The median number of patients
recruited per country and per ICU was 104 and 12, respec-
tively. Demographics of the patients included in the ﬁnal ana-
lyses are presented in Table 1.
Table 1. Demographics of Included Nonelective Patients
No. of patients %
Total 3730 100
ICU mortality 1065 28.6
30-day mortality 1562 41.9
Male 1932 51.8
Age, y, median (25th percentile-75th
percentile)
84 (81-87) -
CFS, median (25th percentile-75th
percentile)
4 (3-6) -
SOFA score, median (25th
percentile-75th percentile)
7 (4-11) -
Intubation and mechanical ventilation 1924 51.6
Vasoactive drugs 2155 57.8
NIV 984 26.4
RRT 405 10.9
Reason for ICU admission
Respiratory failure 900 24.1
Circulatory failure 537 14.4
Respiratory and circulatory failure 448 12
Sepsis 480 12.9
Multi-trauma without head injury 55 1.5
Multi-trauma with head injury 57 1.5
Head injury 110 2.9
Intoxication 13 0.3
Nontrauma 293 7.9
Emergency surgery 379 10.2
Other 458 12.3
Abbreviations: CSF, Clinical Frailty Scale; ICU, intensive care unit; NIV,
noninvasive ventilation; RRT, renal replacement therapy; SOFA, Sequential
Organ Failure Assessment.
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Multivariable Logistic Regression Model
No multicollinearity was found between the variables avail-
able for model development, and there was no interaction
between age and theClinical Frailty Scale. Duringmodel devel-
opment, the following variables were selected using the Lasso
procedure: age, sex, reason for ICU admission categorized into
11 options (Supplementary Materials S1), vasoactive drugs,
Clinical Frailty Scale, SOFA score, intubation with mechanical
ventilation, and RRT. The continuous variable SOFA score
was included as restricted cubic spline. The ﬁnal regression
model is presented in Table 2, where the SOFA score for sim-
pliﬁcation is presented as categorical data instead of splines.
The overall discrimination and accuracy of the ﬁnal regres-
sion model that predicts mortality within 30 days after ICU
admission was good; the area under the curve (AUC) was .80
(.80-.81). The Brier score was .18 (.18-.18). In the different diag-
nostic subgroups, the performance of the model was also good
(Supplementary Materials S2). The calibration belt of the sepsis
patients showed more uncertainty for the low- and high-risk
patients; for the emergency surgery patients, the model is not
able to predict high mortality risks. However, the calibration
belt of the total population and all other diagnostic subgroups
showed no abnormalities (SupplementaryMaterials S3).
“Bedside” Model
The “bedside”model, based on a point system (Supplementary
Materials S4), shows parameters that inﬂuence mortality
30 days after ICU admission and the weight assigned to these
variables. In theory, the minimum and maximum scores a
patient can obtain are 0 and 26 points, respectively. The mini-
mum and maximum scores obtained in the study population
were 1 and 26, respectively. The reason for ICU admission and
the SOFA scorewere the twomost important factors associated
with 30-day mortality. Among the reasons for ICU admission,
multi-trauma with head injury and nontrauma central nervous
system causes were associated with a high 30-daymortality.
The sensitivity and speciﬁcity for various thresholds is
based on the assigned number of points in the predictionmodel
(ie, CPS of the patients) (Figure 1). When all patients with a
30-day CPS higher than 10 points are selected (corresponding
to 76.0% of all patients), 91.8% of all patients who died dur-
ing the 30 days after ICU admission are captured (sensitivity).
Of these 76.0% selected patients, 50.6% will die during the
30 days after ICU admission (positive predicted value).
Supplementary Materials S5 lists the characteristics of
the patients with a 30-day CPS higher than 10 points and
the patients with a 30-day mortality score higher, lower, or
equal to 10 points.
DISCUSSION
This study demonstrates that a cumulative event model corre-
lates with outcome in acutely admitted ICU patients older than
80 years. This model is based on reason for ICU admission,
age, sex, frailty, SOFA score (all available at admission), and
the organ support during ICU stay: invasive mechanical venti-
lation and RRT. Although this model discriminates between
those dying and surviving 30 days after ICU admission rather
accurately (AUC = .80), it remains difﬁcult to predict which
patients are going to die with 100% certainty. Even if we use a
high cutoff (eg, >19 points), these patients still have a 25%
chance of survival in the ﬁrst 30 days after ICU admission.
Table 2. Final Multivariable Regression Model
Covariate Odds ratio 30-day mortality
Age 1.05 (1.03-1.07)
Sex, male 1.26 (1.09-1.47)
Mechanical ventilation 2.07 (1.72-2.50)
RRT 1.70 (1.33-2.18)
CFS 1.19 (1.14-1.25)
SOFA score
<4 Reference
≥4 and <7 1.80 (1.37-2.37)
≥7 and <10 2.70 (2.02-3.60)
≥10 4.40 (3.26-5.92)
Reason for ICU admission
Respiratory failure 3.58 (.73-17.48)
Circulatory failure 3.74 (.76-18.39)
Respiratory and circulatory failure 4.55 (.92-22.43)
Sepsis 3.20 (.65-15.77)
Multi-trauma without head injury 3.62 (.66-19.77)
Multi-trauma with head injury 5.06 (.94-27.23)
Isolated head Injury 4.30 (.84-22.09)
Intoxication Reference
Nontrauma CNS causes 5.45 (1.10-27.01)
Emergency surgery 1.87 (.38-9.27)
Other 2.0 (.40-9.88)
Abbreviations: CFS, Clinical Frailty Scale; CNS, central nervous system;
ICU, intensive care unit; RRT, renal replacement therapy; SOFA, Sequential
Organ Failure Assessment.
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Figure 1. Sensitivity and speciﬁcity of the simple bedside model
for 30-day mortality. When a patient has >10 points on the
Cumulative Prognostic Score (CPS), that patient has a 50.6%
positive predictive value (PPV) on 30-day mortality and a nega-
tive predictive value (NPV) of 85.8%. The other values are as
follows: at >12 points, a PPV of 55.9% and an NPV of 81.1%;
at >16 points, a PPV of 67.6% and an NPV of 69.2%; and at
>20 points, a PPV of 77.0% and an NPV of 60.5%.
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Previous research identiﬁed variables associated with a
poor outcome in this very old patient group: age,1,4 sex,4,9
mechanical ventilation,16 circulatory shock,17 acute kidney
injury,18 and the presence of comorbidities.19 However, up to
now, only a few studies have tried to build a model from these
variables to predict outcome after ICU admission. Ball et al
developed a model based on age, serum creatinine, Glasgow
Coma Scale, and pH.10 The data in that study were collected
during the ﬁrst day of ICU admission and did not include the
response to active treatment for which the ICU trial is
intended. Heyland et al made a model to predict functional
outcome 1 year after ICU admission.9 Although that model
had a good performance (AUC = .81), the selected variables
were less easily collected at the bedside because they were
derived from more complex scores, for example, the Acute
Physiology, Age, Chronic Health Evaluation II score and the
Charlson Comorbidity Index.
It is very difﬁcult to predict outcome in acutely ill patients
older than 80 years, and many are admitted to the ICU for an
ICU trial. However, such an admission should be reevaluated in
a shared decision-making conference with the patient or, when
the patients lack decision-making capacity, with the family or
designated surrogate. Our model can be used to estimate, in a
more objective way than just subjective clinical intuition, what
the chances of 30-day mortality will be.We believe this informa-
tion can help both the intensivist and the family members to put
treatment into perspective.20 Indeed, although almost all intensi-
vists claim that they value the opinions of surrogates (eg, rela-
tives, family, legal representatives, and caregivers),21 these family
opinions on ICU admissions are, in reality, rarely sought.8,22
One of the reasons why this is omitted is the uncertainty that
intensivists feel during the prognostication of patients.22–25
And yet, a poor prognosis is one of the most important
reasons to implement limitations in life-sustaining thera-
pies.26,27 Indeed, familymembers reported that what was most
important to themwas that the “patient should be comfortable
and suffer as little as possible.” The belief that “life should be
preserved at all costs” was their least important value consid-
ered in making treatment decisions. A substantial proportion
of the caregivers (24%) reported that “comfort care without
life support” was their most preferred treatment goal, but
14%were “unsure about their treatment preferences.”28 Care-
givers and surrogates who had a shared decision-making con-
ference with their intensivist experienced less decisional
conﬂicts than family members who had not talked to a physi-
cian.28 Strikingly, despite family members only prioritizing
“comfort measures,” 83.7% of these patients still received life-
sustaining treatments, and approximately 20% received such
treatments for more than a week.28 Our bedside model for
30-day mortality can assist both intensivists and family mem-
bers in the decision-making process to continue or cease fur-
ther treatment.
The strong feature of this study is the international inclu-
sion ofmore than 3700 very old patients and the high follow-up
rate at 30 days after ICU admission. However, some limitations
need to be discussed. First, we did not collect data on the timing
of discussions to withhold or withdraw life-sustaining treat-
ment. For example, some patients had advanced directives not
to instigate certain treatments that might have inﬂuenced out-
come. A second limitation of themodel is that it does not predict
patients who will have a deﬁnite poor outcome (100% mortal-
ity). The predictedmortality at more than 19 points is 75%, but
this means that 25% of those patients do survive the ﬁrst
30 days. A longer follow-up will undoubtedly show there is
substantial additional mortality in these very old patients. For
this reason a new study (the so-called Very old Intensive care
Patient study 2 [VIP2]) will look at mortality at day 180 after
ICU admission. Third, we combined data from admission with
treatment data from the subsequent treatment days. This
simpliﬁes and strengthens prognostication but prevents the
model being used for triage purposes before admission. Fourth,
we only looked at survival, although we know that many
patients do not fully recover, and many older adult patients pri-
oritize “quality of life” above “quantity of life.” Future research
should focus on functional outcome and quality of life. And,
ﬁnally, we did not include data on nutritional status, functional
status (activities of daily living and instrumental activities of
daily living), cognitive impairment, dementia, delirium, depres-
sion, and comorbidities (eg, active cancer). These variables will
undoubtedly inﬂuence outcome. Our CPS can become more
comprehensive if such variables are included.
In conclusion, this relatively simple cumulative events
model can help assess the chances of 30-day mortality in
very old patients who were acutely admitted to the ICU.
This model may assist both intensivists and family members
during the shared decision-making process to estimate the
otherwise subjective chances of survival.
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